Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aspira Women's Health (AWH)
NASDAQ:AWH
RESEARCH TOOLSreports
Holding AWH?
Track your performance easily
Earnings Data
Report Date
Mar 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.21Last Year’s EPS
-$0.3Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 14, 2024
|% Change Since: -6.10%
|Next Earnings Date:Mar 27, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in product development and commercial execution, which resulted in increased test volumes and expanded market opportunities. However, challenges remain in terms of operating costs, cash reserves, and achieving broader payer coverage. The sentiment is cautiously optimistic with substantial achievements, yet underlying financial and operational challenges persist.Company Guidance
During the second quarter of 2024, Aspira Women's Health Inc. reported significant developments and growth metrics. The company launched a new longitudinal monitoring application for their OVA Watch test, expanding the total addressable market for their ovarian cancer risk assessment tests to between 2 million and 4 million tests annually. This was a tenfold increase from the initial market size. The OVA Watch test volume alone saw a 48% year-over-year increase and contributed 20% to the total test volume, which reached a new high of 6,471—an 11% sequential increase and a 3% year-over-year growth. The company managed this growth with 17% fewer field salespeople, achieving a 29% increase in test volume per representative. Financially, the average unit price per test was $374, and the company's overall gross margin was 59%. Aspira's cash used in operations for the quarter was $3.7 million, with an updated guidance for 2024 projecting cash use between $13 million and $14.5 million.Launch of Longitudinal Monitoring Application for OVA Watch
Aspira Women's Health launched a new application for OVA Watch, expanding the addressable market for their ovarian cancer risk assessment blood test to between 2 million and 4 million tests per year, representing a tenfold increase.
Record Test Volume Achieved
The company achieved a new high with 6,471 tests in the second quarter, with more than 20% of that volume from the OVA Watch test. This was accomplished with 17% fewer salespeople, indicating a 29% increase in volume per salesperson.
Significant Growth in Reimbursement Coverage
Aspira successfully contracted with multiple insurance plans, adding coverage for 8 million lives. They expect further contracts to add 16 million more lives by the end of 2024.
Progress in Product Development
Significant advancements were made in research and development, including the publication of manuscripts supporting the clinical utility of OVA Watch and progress on EndoCheck and OVAMDx tests.
Reduction in Cash Usage
Cash used in operations decreased by 16% sequentially. The company expects cash usage for operations in 2024 to be between $13 million and $14.5 million, down from previous estimates.
---
AWH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AWH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $0.82 | $0.74 | -9.76% |
| Aug 12, 2024 | $1.13 | $1.09 | -3.54% |
| May 15, 2024 | $2.90 | $2.78 | -4.14% |
| Mar 28, 2024 | $3.43 | $3.10 | -9.62% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Aspira Women's Health (AWH) report earnings?
Aspira Women's Health (AWH) is schdueled to report earning on Mar 27, 2025, TBA Not Confirmed.
What is Aspira Women's Health (AWH) earnings time?
Aspira Women's Health (AWH) earnings time is at Mar 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AWH EPS forecast?
AWH EPS forecast for the fiscal quarter 2024 (Q4) is -$0.21.
---